Archives
-
Palomid 529 in ESCC Research Workflows
2026-09-10
Palomid 529 (P529) provides a practical way to interrogate dual mTORC1 and mTORC2 signaling in esophageal squamous cell carcinoma models. This guide connects pathway validation with cisplatin resistance, metastasis, tumor angiogenesis inhibition, and radiotherapy enhancement while emphasizing reproducible dosing and troubleshooting.
-
SAG for Hedgehog Pathway Assays and Models
2026-09-09
SAG provides a controllable Smoothened receptor agonist signal for reporter assays, mechanistic inhibitor studies, neurobiology, developmental models, and translational disease research. This guide combines product-specific handling data with an assay strategy that distinguishes Smoothened-level effects from downstream GLI activity.
-
Rotavirus Suppression of Nrf2 Redox Defense
2026-09-09
The reference study shows that rotavirus infection produces a biphasic Nrf2 response: an early, redox-sensitive induction followed by pronounced loss of Nrf2 and its antioxidant transcriptional program. Its key contribution is linking late Nrf2 depletion to proteasome-sensitive, K48-linked ubiquitination rather than simply attributing the change to sustained oxidative stress.
-
Carbapenemase Gene Transmission in CREC
2026-09-08
Chen et al. combine gene localization, antimicrobial susceptibility, conjugation, mobile-element analysis, and genotyping to examine carbapenem-resistant Enterobacter cloacae across eight Guangdong teaching hospitals. The study shows that plasmid-associated blaNDM-1 is common and highly transferable, while strain relatedness and clinical distribution indicate simultaneous horizontal and vertical dissemination.
-
Anisomycin: JNK Agonist for Apoptosis Research
2026-09-08
Anisomycin is a JNK agonist and stress-signaling research compound used to study JNK pathway activation in apoptosis, cancer biology, and cellular stress. Product documentation identifies SKU B6674 as a 265.31 g/mol solid that is soluble in DMSO and ethanol but insoluble in water.
-
Deferiprone Workflows for Iron-Stress Research
2026-09-07
Deferiprone enables controlled iron depletion studies spanning enterocyte metabolism, tumor biology, oxidative stress, and vascular injury. This workflow-focused guide translates recent IPEC-J2 findings into practical dosing, repletion, metabolomics, and troubleshooting strategies.
-
JC-1 Mitochondrial Membrane Potential Assay Guide
2026-09-07
Learn how to use the JC-1 Mitochondrial Membrane Potential Assay Kit for ratiometric apoptosis assay design, drug screening, and mitochondrial function analysis. The workflow emphasizes CCCP controls, treatment-matched timing, and practical interpretation of mitochondrial depolarization in cancer research.
-
X-press Tag Peptide for Protein Purification
2026-09-05
X-press Tag Peptide is an N-terminal leader peptide that combines polyhistidine capture, an Xpress epitope, and an enterokinase cleavage site. Its documented 99.23% purity, ProBond compatibility, and anti-Xpress antibody detection support recombinant protein purification workflows, while the cited RHEB study provides biological context rather than direct product validation.
-
IPR-803: Urokinase Receptor Inhibitor Workflows
2026-09-04
IPR-803 is a competitive urokinase receptor inhibitor for separating uPAR–uPA signaling from general cell motility. Its use spans breast cancer invasion assays, metastasis models, and delivery-enabled pancreatic tumor-stroma research.
-
Substance P Workflows for Reproducible NK-1 Studies
2026-09-04
Build reproducible Substance P experiments for pain transmission research, neuroinflammation, and immune response modulation with water-based preparation and clearly staged controls. A fluorescence-quality-control strategy adapted from a recent reference study adds a practical way to detect matrix interference without overstating what EEM can prove.
-
PD 173074: An Epigenetics-Aware FGFR Assay Strategy
2026-09-03
PD 173074 enables precise investigation of FGFR1 and VEGFR2 signaling, but response can depend on cellular epigenetic context. This guide translates HNSCC methylation findings into a practical, target-engagement-focused assay strategy.
-
MG-132 and TDP-43 Aggregation: Assay Logic
2026-09-03
MG-132 (Z-LLL-al) is more than an apoptosis reagent: it can expose how proteasome impairment reshapes TDP-43 aggregation and localization. This article translates the key findings of a 2023 EMBO Journal study into practical assay-design decisions for neurobiology and cancer research.
-
Brefeldin A: Reliable ER Stress Assays
2026-09-02
This scenario-driven guide explains how Brefeldin A, SKU B1400, can improve the interpretation of cell viability, proliferation, cytotoxicity, and protein-trafficking experiments. It connects dose and solvent planning with ER-stress biology, apoptosis, and practical vendor-selection criteria.
-
Aztreonam: Mechanism and Research Evidence
2026-09-02
Aztreonam is a monocyclic β-lactam antibiotic with selective activity against Gram-negative aerobic bacteria. Its research profile combines inhibition of bacterial cell wall synthesis with documented effects on bone marrow progenitor cells and liver cytochrome P450 enzymes.
-
Praeruptorin A: From Target Lists to Translation
2026-09-01
Praeruptorin A is an angular pyranocoumarin compound with a translationally relevant profile spanning iron overload, inflammation, epithelial barrier repair, metastatic behavior, and doxorubicin-associated cardiac injury. This thought-leadership guide shows how to convert those mechanisms into rigorous, decision-oriented research programs.